Q&A With Prostate Cancer Survivor Mical J. Roy
Mical J. Roy, a young prostate cancer survivor, shares his experience and words of advice. 1. How and when were you diagnosed with prostate cancer? In the summer of 2018,...Read More
PSMA Targeted Therapy Trial Results: New Hope For Men With Prostate Cancer
There is incredibly hopeful news on the horizon for men with metastatic castration-resistant prostate cancer (mCRPC). Today, promising results were released from a clinical trial of a revolutionary new class...Read More
A Message From Our CEO, Dr. Jonathan Simons
To our entire PCF community… Leading PCF for 14 years and collaborating with Mike Milken, the Board of Directors, our exceptional staff, the many researchers and physicians who share our...Read More
Breaking News: FDA Approves a Highly Sensitive Prostate Cancer Imaging Agent
What this means for patients: Today, the FDA approved another highly sensitive imaging compound specifically for prostate cancer called 18F-DCFPyL. This is the second such approval in less than six...Read More
How Far Did I Go?
Since you can clock your miles any way you want this month (biking, swimming, running, tennis, dancing, etc.), how are you going to track your distance? Here are some suggestions:...Read More
Cutting-Edge Science to Reduce Radiation Side Effects: Q&A with Dr. James Byrne
Radiation is an important option in treating localized prostate cancer, as well as in caring for patients with advanced prostate cancer, but it also has some side effects. With funding...Read More
A Classic Dish for Spring
What better time than April to try your hand at pasta primavera? It’s the perfect crossover from winter stew to summer salads. Primavera literally means “lightly sautéed spring vegetables” and...Read More
PCF Investigator Dr. Karen Knudsen To Lead American Cancer Society
PCF congratulates Karen Knudsen, PhD, MBA in her new role as the next chief executive officer of the American Cancer Society (ACS) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), starting June 1,...Read More
Highlights of GU-ASCO 2021: Prostate-Targeting Radionuclide Treatment, Oral Docetaxel, and More
The American Society of Clinical Oncology (ASCO) recently held its 2021 Genitourinary Cancers Symposium virtually. These meetings provide opportunities for clinicians and researchers to share and discuss the latest clinical...Read More
The Benefits of Fish
Fish, especially salmon and other dark-meat fish, is anti-inflammatory. What’s the problem with inflammation? It’s a good thing when you see local inflammation, like swelling around a paper cut: immune...Read More